Skip to content

Mankind Pharma Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Tue, Jan 26, 2027, before the market opens · estimates and history

Mankind Pharma Ltd · E.MANKIND.NSE · India
Use symbol E.MANKIND.NSE in our API & Excel add-in to retrieve this data ↓
2,481.20
(0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 43.86%

Mankind Pharma Ltd Forecast

Mankind Pharma Ltd short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 43.9% a year, a typical one-standard-deviation range is 2,328–2,634 over a week, 2,167–2,795 over a month and 1,393–3,570 over a year. (Signals as of 5 Nov 2026.)

Mankind Pharma Ltd Price Chart

MacroFinance.ai

Mankind Pharma Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Mankind Pharma Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Mankind Pharma Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Mankind Pharma Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Mankind Pharma Ltd
P/E
45.77x
Cheap vs own history
QoQ −5.2%
YoY −13.5%
now 45.765340.81 low54.09 high
ⓘP/E As of 22 Nov 2026.See Mankind Pharma Ltd returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Mankind Pharma Ltd
P/S
6.67x
Cheap vs own history
QoQ −0.2%
YoY −2.9%
now 6.67395.79 low7.25 high
ⓘP/S As of 22 Nov 2026.See Mankind Pharma Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Mankind Pharma Ltd
P/B
5.84x
Cheap vs own history
QoQ −1.9%
YoY −3.7%
now 5.83745.07 low6.35 high
ⓘP/B As of 22 Nov 2026.See Mankind Pharma Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Mankind Pharma Ltd
EV/EBITDA
24.58x
Cheap vs own history
QoQ −10.7%
YoY −5.7%
now 24.581121.99 low27.95 high
ⓘEV/EBITDA As of 22 Nov 2026.See Mankind Pharma Ltd returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Mankind Pharma Ltd
EV/Sales
6.85x
Cheap vs own history
QoQ −7.8%
YoY −5.7%
now 6.85356.09 low7.55 high
ⓘEV/Sales As of 22 Nov 2026.See Mankind Pharma Ltd returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Mankind Pharma Ltd
Earnings Yield
2.2%
Strong vs own history
QoQ +5.4%
YoY +15.6%
now 2.18511.85 low2.45 high
ⓘEarnings Yield As of 22 Nov 2026.See Mankind Pharma Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Mankind Pharma Ltd
Market Cap
$1.03T
Mid-range vs own history
QoQ +4.1%
YoY +10.8%
now 1026350.8612826,152 low1,102,380 high
ⓘMarket Cap As of 22 Nov 2026.See Mankind Pharma Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Mankind Pharma Ltd
Net Debt
$27.6B
Mid-range vs own history
QoQ −35.7%
YoY −47.5%
now 27614.827,615 low52,640 high
ⓘNet Debt As of 22 Nov 2026.See Mankind Pharma Ltd returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Mankind Pharma Ltd
Net Debt / EBITDA
0.64x
Mid-range vs own history
QoQ −42.1%
YoY −54.1%
now 0.6440.64 low1.4 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Mankind Pharma Ltd returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Mankind Pharma Ltd
Current Ratio
1.35x
Mid-range vs own history
QoQ +26.5%
YoY +18.3%
now 1.3521.07 low1.35 high
ⓘCurrent Ratio As of 22 Nov 2026.See Mankind Pharma Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Mankind Pharma Ltd
Quick Ratio
0.95x
Mid-range vs own history
QoQ +29.0%
YoY +10.2%
now 0.95350.74 low0.95 high
ⓘQuick Ratio As of 22 Nov 2026.See Mankind Pharma Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Mankind Pharma Ltd
Interest Coverage
6.58x
Mid-range vs own history
QoQ +21.3%
YoY +70.8%
now 6.57873.85 low6.58 high
ⓘInterest Coverage As of 22 Nov 2026.See Mankind Pharma Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Mankind Pharma Ltd
Debt / Equity
0.31x
Mid-range vs own history
QoQ −20.4%
YoY −43.7%
now 0.30840.31 low0.55 high
ⓘDebt / Equity As of 22 Nov 2026.See Mankind Pharma Ltd returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Mankind Pharma Ltd
Piotroski F-Score
3
3
QoQ 0.0%
YoY +200.0%
now 31 low3 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Mankind Pharma Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
  15 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  15 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Mankind Pharma Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Mankind Pharma Ltd fundamentals: income statement, balance sheet & cash flow

Mankind Pharma Ltd reported revenue of 142.78bn INR and net income of 19.13bn INR in FY2026, the year ended 31 March 2026 — revenue up 17.0% and net income down 3.9% on the prior year. Free cash flow was 18.90bn INR. These figures are as reported in the filings, not restated: 8 fiscal years and 19 quarters of history, back to March 2019.

Revenue (FY2026)
142.78bn INR
+17.0%
Net income
19.13bn INR
-3.9%
Gross margin
43.11%
Free cash flow
18.90bn INR
-3.2%
Net debt
58.29bn INR
Mankind Pharma Ltd income statement, annual, as reported · INR billions unless stated
INR billionsFY2026FY2025FY2024FY2023FY2022
Period end31 Mar 202631 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Revenue142.78122.07102.5987.4977.82
Cost of revenue81.2235.6932.5729.6224.70
Gross profit61.5586.3870.0257.8753.12
Research & development—2.320.250.250.02
Selling, general & admin.15.0158.9047.3741.2034.26
Operating income27.3125.1622.3916.4218.84
EBITDA38.5835.5828.2420.3721.97
Interest expense6.394.080.280.420.20
Pre-tax income23.3325.1623.9816.7119.75
Income tax3.955.104.573.625.22
Net income19.1319.9119.1312.8214.33

Download Mankind Pharma Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.MANKIND.NSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks the full history, the filing vintages behind each number and API access.
Create free account

Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Mankind Pharma Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Mankind Pharma Ltd Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Mankind Pharma Ltd; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Mankind Pharma Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Mankind Pharma Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Mankind Pharma Ltd (India)

Mankind Pharma Ltd is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Mankind Pharma Ltd?
Mankind Pharma Ltd is a listed security in India. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Mankind Pharma Ltd price?
The latest close is 2,481 (5 Nov 2026), -0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Mankind Pharma Ltd in an uptrend?
As of 5 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Mankind Pharma Ltd?
20-day realised volatility is 43.9% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 12.7% over a month and 6.2% over a week.
What factors affect Mankind Pharma Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Mankind Pharma Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Mankind Pharma Ltd?
28 backtested tactical asset allocation strategies trade Mankind Pharma Ltd through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Mankind Pharma Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Mankind Pharma Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Mankind Pharma Ltd historical data?
In the Free historical data section of this page: the last 10 years of Mankind Pharma Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Mankind Pharma Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Mankind Pharma Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MANKIND.NSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-202665
2026-11-192629
2026-11-182625
2026-11-172610
2026-11-162626.6
2026-11-132640
2026-11-122638.6
2026-11-112660
2026-11-092668.3
2026-11-082582.9
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural and pet food products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Telmikind-Am, Gudcef, Glimestar-M, Candi Force, Nurokind-Gold, Telmikind-H, Telmikind, Nurokind-Lc, Nurokind Plus-Rf, Vomikind, Cefakind, Glizid-M, Monticope, and Gudcef-Cv brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.